# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001125345-22-000039
Filing Date
2022-04-08
Accepted
2022-04-08 16:06:35
Documents
4
Period of Report
2022-05-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def_14ax2022.htm | DEF 14A | 679870
2 |  | imagea.jpg | GRAPHIC | 7365
3 |  | macrogenicscard22v1_pagex1a.jpg | GRAPHIC | 673921
4 |  | macrogenicscard22v1_pagex2a.jpg | GRAPHIC | 188958
| Complete submission text file | 0001125345-22-000039.txt |  | 1879663

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 22817027
SIC: 2834 Pharmaceutical Preparations